comprehensive -WSS

comprehensive

author：knowledge 2025-10-02 00:43:06 - browse：3

John Crowley pictured with his daughter Megan Crowley — health policy news from STAT — John Crowley pictured with his daughter Megan. Crowley family

WASHINGTON — The Biotechnology Innovation Organization has chosen longtime biotech executive and rare disease advocate John Crowley as its new CEO, the organization announced Tuesday.

Crowley came to biotech when his children were diagnosed with a rare genetic neuromuscular disease. He started working at Bristol Myers Squibb, and started Novazyme, which was eventually successful in creating an enzyme replacement therapy for Pompe disease. He later started and worked for several different biotech companies, most recently with Amicus Therapeutics, which had a drug approved to treat the disease in September.

The trade association’s board chair, Ted Love, served on the board of the company.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： AI used to predict Covid

WSS

Childbirth

What will save rural psychiatry services? Higher Medicaid payments

Focused ultrasound for uterine fibroids: an uphill battle

Biohaven protein

Mifepristone protocols being wielded by pill's opponents in Supreme Court case

Stigma and the return of syphilis

knowledge

comprehensive

Wikipedia

Alkermes shareholders re

Startling documents reveal new facets of Sacklers' opioid empire

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Childhood vaccination ad campaign launches in the U.K.

Psychedelics group wrestles with new pharma identity

Pfizer is about to make a big push in cancer. Will investors listen?

Dobbs anniversary: the lost opportunity of abortion as health care

CDC advisory group OKs chikungunya vaccine

Peter Hotez and the public health issue of online harassment

Antibiotic resistance nearly killed me, so I'm raising awareness of it

focus

Merus drug and Keytruda shrank tumors in patients with head and neck cancer

Heat waves linked to early deliveries, preterm births in new study

Pfizer is about to make a big push in cancer. Will investors listen?

STAT Madness 2024: Meet the contenders

STAT Madness 2024: Meet the contenders

Doctor of U.S. President Joe Biden says he is fit for duty

leisure time

entertainment

knowledge

knowledge